Investing21 天
Centessa's SWOT analysis: narcolepsy drug could wake up stock potential
The company's lead candidate, ORX750, an orexin agonist for the treatment of narcolepsy, is poised to potentially reshape the landscape of sleep disorder therapeutics. As Centessa prepares to unveil ...
Investing21 天
Centessa's SWOT analysis: narcolepsy drug could wake up stock potential
The company's lead candidate, ORX750, an orexin agonist for the treatment of narcolepsy, is poised to potentially reshape the landscape of sleep disorder therapeutics. As Centessa prepares to ...